Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart surgery recovery gets a wireless watchdog

NCT ID NCT07736066

Disease control Sponsor: HUINNO Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether a wearable ECG patch can help people recover better after heart surgery. Participants wear the MEMO Patch, which continuously records heart signals and activity, while completing a cardiac rehabilitation program that starts in the hospital and continues at home. Researchers will measure changes in exercise capacity, muscle strength, and quality of life to see if remote monitoring improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a wearable adhesive ECG monitoring device called MEMO Patch, plus a Phase I cardiac rehabilitation program
What this could lead to
If it works, this could make cardiac rehabilitation safer and more effective by allowing doctors to monitor patients remotely after heart surgery.
What could go wrong
This is a small, single-arm study with only 22 participants, so results may not apply to all heart surgery patients. The device may cause skin irritation or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Aug 2021

Finished

Aug 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older * Patients diagnosed with cardiovascular disease (e.g., acute coronary syndrome, heart failure, or valvular heart disease) who have undergone cardiac surgery * Low- or intermediate-risk patients with a left ventricular ejection fraction (LVEF) of 35% or greater on echocardiography * Patients with sufficient cognitive ability to understand the cardiac rehabilitation program using a mobile device, application, and the MEMO Patch * Patients who were independently ambulatory prior to surgery * Patients capable of undergoing an exercise stress test * Patients who voluntarily provide written informed consent to participate in the study Exclusion Criteria: * High-risk patients (e.g., patients with aortic dissection, survivors of cardiac arrest or sudden cardiac death, or patients with an implantable cardioverter-defibrillator) * Patients with uncontrolled medical diseases * Patients who are unable to walk independently * Patients with contractures of the hip, knee, or ankle joints that interfere with walking * Patients with musculoskeletal or neurological disorders affecting the lower extremities * Patients with physical conditions that preclude high-intensity gait training * Patients receiving other treatments that may affect the safety or efficacy assessments * Patients who do not provide written informed consent to participate in this clinical study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rehabilitation Cardiac surgery Heart disease

Contacts and locations

Locations

  • Korea University Anam Hospital

    Seoul, 02841, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.